US Stock MarketDetailed Quotes

CNTA Centessa Pharmaceuticals

Watchlist

9.250
+0.330+3.70%

Trading Apr 29 15:56 ET

1.03BMarket Cap-5891P/E (TTM)

Centessa Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

20.05%-160.34M

39.78%-31.05M

4.34%-37.39M

26.41%-44.06M

4.36%-47.84M

-200.55M

-51.56M

-39.09M

-59.88M

-50.02M

Net income from continuing operations

30.12%-151.09M

14.68%-36.84M

28.26%-38.65M

61.51%-24.89M

6.94%-50.71M

---216.21M

---43.17M

---53.88M

---64.66M

---54.5M

Depreciation and amortization

518.32%810K

583.33%246K

580.00%238K

640.63%237K

217.86%89K

--131K

--36K

--35K

--32K

--28K

Deferred tax

-828.56%-26.53M

94.63%-149K

-2,040.74%-2.89M

----

---2.86M

---2.77M

---135K

----

Other non cash items

-83.82%28K

---67K

----

---825K

--173K

----

Change In working capital

-566.13%-18.86M

75.98%-3.37M

-162.97%-4.45M

-187.13%-5.66M

-129.34%-5.38M

---2.83M

---14.04M

--7.06M

--6.5M

---2.35M

-Change in receivables

-3.25%-12.09M

-105.36%-7.94M

8.83%-2.32M

-1,534.81%-6.14M

175.17%4.31M

---11.71M

---3.86M

---2.55M

--428K

---5.73M

-Change in prepaid assets

63.45%-1.36M

123.26%1.85M

-174.32%-2.48M

-130.30%-2.63M

-5.71%1.9M

---3.73M

---7.94M

--3.34M

---1.14M

--2.01M

-Change in payables and accrued expense

-127.90%-3.52M

217.52%2.63M

-96.33%230K

-27.83%5.2M

-946.09%-11.58M

--12.61M

---2.24M

--6.27M

--7.21M

--1.37M

-Change in other current assets

---1.88M

--85K

----

--0

----

Cash from discontinued investing activities

Operating cash flow

20.05%-160.34M

39.78%-31.05M

4.34%-37.39M

26.41%-44.06M

4.36%-47.84M

---200.55M

---51.56M

---39.09M

---59.88M

---50.02M

Investing cash flow

Cash flow from continuing investing activities

-13,541.68%-127M

-3,997.53%-18.28M

304,512.50%48.71M

-30,947.60%-71.1M

-35,873.33%-86.34M

-931K

-446K

-16K

-229K

-240K

Net PPE purchase and sale

85.14%-169K

95.71%-28K

-168.75%-43K

95.63%-10K

63.33%-88K

---1.14M

---652K

---16K

---229K

---240K

Net investment purchase and sale

---126.84M

---18.25M

--48.75M

---71.09M

---86.25M

--0

Net other investing changes

----

--206K

----

Cash from discontinued investing activities

Investing cash flow

-13,541.68%-127M

-3,997.53%-18.28M

304,512.50%48.71M

-30,947.60%-71.1M

-35,873.33%-86.34M

---931K

---446K

---16K

---229K

---240K

Financing cash flow

Cash flow from continuing financing activities

4,520.79%21.12M

7,047.19%6.36M

6,482.14%14.74M

-82.86%12K

457K

89K

224K

70K

74K

Net common stock issuance

--20.81M

--6.24M

----

--0

----

Proceeds from stock option exercised by employees

-56.82%310K

32.58%118K

-19.64%180K

-82.86%12K

--0

--718K

--89K

--224K

--70K

--335K

Net other financing activities

----

---261K

--0

---261K

Cash from discontinued financing activities

Financing cash flow

4,520.79%21.12M

7,047.19%6.36M

6,482.14%14.74M

-82.86%12K

--0

--457K

--89K

--224K

--70K

--74K

Net cash flow

Beginning cash position

-33.85%393.64M

-61.45%171.5M

-70.01%145.22M

-52.25%259.99M

-33.85%393.64M

--595.08M

--444.84M

--484.16M

--544.47M

--595.08M

Current changes in cash

-32.44%-266.23M

17.25%-42.96M

167.02%26.06M

-91.80%-115.15M

-167.37%-134.17M

---201.02M

---51.92M

---38.88M

---60.04M

---50.18M

Effect of exchange rate changes

247.13%615K

-169.81%-504K

150.23%220K

242.16%381K

219.35%518K

---418K

--722K

---438K

---268K

---434K

End cash Position

-67.48%128.03M

-61.45%171.5M

-70.01%145.22M

-52.25%259.99M

--393.64M

--444.84M

--484.16M

--544.47M

Free cash flow

20.41%-160.51M

40.48%-31.08M

4.27%-37.44M

26.68%-44.07M

4.64%-47.93M

---201.68M

---52.22M

---39.1M

---60.11M

---50.26M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	20.05%-160.34M	39.78%-31.05M	4.34%-37.39M	26.41%-44.06M	4.36%-47.84M	-200.55M	-51.56M	-39.09M	-59.88M	-50.02M
Net income from continuing operations	30.12%-151.09M	14.68%-36.84M	28.26%-38.65M	61.51%-24.89M	6.94%-50.71M	---216.21M	---43.17M	---53.88M	---64.66M	---54.5M
Depreciation and amortization	518.32%810K	583.33%246K	580.00%238K	640.63%237K	217.86%89K	--131K	--36K	--35K	--32K	--28K
Deferred tax	-828.56%-26.53M	94.63%-149K	-2,040.74%-2.89M	----	----	---2.86M	---2.77M	---135K	----	----
Other non cash items	-83.82%28K	---67K	----	----	---825K	--173K	----	----	----	----
Change In working capital	-566.13%-18.86M	75.98%-3.37M	-162.97%-4.45M	-187.13%-5.66M	-129.34%-5.38M	---2.83M	---14.04M	--7.06M	--6.5M	---2.35M
-Change in receivables	-3.25%-12.09M	-105.36%-7.94M	8.83%-2.32M	-1,534.81%-6.14M	175.17%4.31M	---11.71M	---3.86M	---2.55M	--428K	---5.73M
-Change in prepaid assets	63.45%-1.36M	123.26%1.85M	-174.32%-2.48M	-130.30%-2.63M	-5.71%1.9M	---3.73M	---7.94M	--3.34M	---1.14M	--2.01M
-Change in payables and accrued expense	-127.90%-3.52M	217.52%2.63M	-96.33%230K	-27.83%5.2M	-946.09%-11.58M	--12.61M	---2.24M	--6.27M	--7.21M	--1.37M
-Change in other current assets	---1.88M	--85K	----	----	----	--0	--0	----	----	----
Cash from discontinued investing activities
Operating cash flow	20.05%-160.34M	39.78%-31.05M	4.34%-37.39M	26.41%-44.06M	4.36%-47.84M	---200.55M	---51.56M	---39.09M	---59.88M	---50.02M
Investing cash flow
Cash flow from continuing investing activities	-13,541.68%-127M	-3,997.53%-18.28M	304,512.50%48.71M	-30,947.60%-71.1M	-35,873.33%-86.34M	-931K	-446K	-16K	-229K	-240K
Net PPE purchase and sale	85.14%-169K	95.71%-28K	-168.75%-43K	95.63%-10K	63.33%-88K	---1.14M	---652K	---16K	---229K	---240K
Net investment purchase and sale	---126.84M	---18.25M	--48.75M	---71.09M	---86.25M	--0	--0	--0	--0	--0
Net other investing changes	----	----	----	----	----	--206K	----	----	----	----
Cash from discontinued investing activities
Investing cash flow	-13,541.68%-127M	-3,997.53%-18.28M	304,512.50%48.71M	-30,947.60%-71.1M	-35,873.33%-86.34M	---931K	---446K	---16K	---229K	---240K
Financing cash flow
Cash flow from continuing financing activities	4,520.79%21.12M	7,047.19%6.36M	6,482.14%14.74M	-82.86%12K	0	457K	89K	224K	70K	74K
Net common stock issuance	--20.81M	--6.24M	----	----	----	--0	--0	----	----	----
Proceeds from stock option exercised by employees	-56.82%310K	32.58%118K	-19.64%180K	-82.86%12K	--0	--718K	--89K	--224K	--70K	--335K
Net other financing activities	----	----	----	----	----	---261K	--0	--0	--0	---261K
Cash from discontinued financing activities
Financing cash flow	4,520.79%21.12M	7,047.19%6.36M	6,482.14%14.74M	-82.86%12K	--0	--457K	--89K	--224K	--70K	--74K
Net cash flow
Beginning cash position	-33.85%393.64M	-61.45%171.5M	-70.01%145.22M	-52.25%259.99M	-33.85%393.64M	--595.08M	--444.84M	--484.16M	--544.47M	--595.08M
Current changes in cash	-32.44%-266.23M	17.25%-42.96M	167.02%26.06M	-91.80%-115.15M	-167.37%-134.17M	---201.02M	---51.92M	---38.88M	---60.04M	---50.18M
Effect of exchange rate changes	247.13%615K	-169.81%-504K	150.23%220K	242.16%381K	219.35%518K	---418K	--722K	---438K	---268K	---434K
End cash Position	-67.48%128.03M	-67.48%128.03M	-61.45%171.5M	-70.01%145.22M	-52.25%259.99M	--393.64M	--393.64M	--444.84M	--484.16M	--544.47M
Free cash flow	20.41%-160.51M	40.48%-31.08M	4.27%-37.44M	26.68%-44.07M	4.64%-47.93M	---201.68M	---52.22M	---39.1M	---60.11M	---50.26M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall